+7 (927) 69-77-224
Nafamostat Mesylate | CAS 82956-11-4 | Serine Protease Inhibitor
Synthetic serine protease inhibitor. First marketed by Japan Tobacco (1986). Approved for inflammation-related conditions such as pancreatitis. High-purity API, low impurities.
Product Name: Nafamostat Mesylate
CAS No.: 82956-11-4
Synonyms:
-
4-((Aminoiminomethyl)amino)-benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate
-
6-Carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate dimethanesulfonate
Molecular Formula: C₁₉H₁₇N₅O₂ · 2(CH₄O₃S) or C₂₁H₂₅N₅O₈S₂
Molecular Weight: 539.58
Purity: ≥98%
Description
Nafamostat mesylate (NM) is a synthetic serine protease inhibitor. First introduced to the market by Japan Tobacco in 1986, it was approved for the treatment of inflammation-related conditions such as pancreatitis.
Product Features
-
High purity
-
Low impurity profile
Available Documentation: COA, HPLC, HNMR, MS upon request
